HYBRID EVENT: You can participate in person at London or Virtually from your home or work.
Arrhythmias In Neonates

Arrhythmias in neonates, defined as irregularities in the heart's rhythm, present a complex and challenging clinical scenario that demands meticulous attention due to the vulnerable nature of new-borns. Neonatal arrhythmias encompass a spectrum of disorders, ranging from benign and self-limiting to severe and life-threatening, posing a diagnostic and therapeutic dilemma for healthcare providers. The etiology of these arrhythmias can be multifactorial, stemming from congenital heart defects, structural abnormalities, or disturbances in the electrical conduction system of the heart. Given the limited capacity of neonatal hearts to adapt to rhythm disturbances, even seemingly innocuous arrhythmias can lead to significant consequences. The clinical presentation varies widely, from subtle symptoms such as feeding difficulties and irritability to more overt signs of distress, such as cyanosis and cardiovascular collapse. Timely and accurate diagnosis is paramount, necessitating a comprehensive evaluation that includes electrocardiography, echocardiography, and continuous monitoring. The management of neonatal arrhythmias involves a delicate balance between intervention and observation, considering the potential for spontaneous resolution and the associated risks of pharmacological or procedural interventions in fragile neonates. Medications such as antiarrhythmics may be employed in some cases, and in critical situations, interventions like cardioversion or pacemaker placement might be considered. Close collaboration among neonatologists, Paediatric cardiologists, and specialized nursing teams is crucial to optimize outcomes. Additionally, educating parents about the condition, its implications, and the importance of follow-up care is integral to ensuring comprehensive and ongoing support for both the neonate and their family. Despite the challenges inherent in managing arrhythmias in neonates, advances in medical technology, coupled with a multidisciplinary approach, continue to improve the prognosis and quality of life for these vulnerable patients.

Committee Members
Speaker at Pediatrics and Neonatology 2025 - Steven M Donn

Steven M Donn

University of Michigan, United States
Speaker at Pediatrics and Neonatology 2025 - Renee J Dufault

Renee J Dufault

Food Ingredient and Health Research Institute, United States
Speaker at Pediatrics and Neonatology 2025 - Catherine Fallet Bianco

Catherine Fallet Bianco

Sainte-Justine University Hospital, Canada
Speaker at Pediatrics and Neonatology 2025 - Hanna Alonim

Hanna Alonim

The Mifne Center for Treatment Research and Training, Israel
Tags

Submit your abstract Today

Watsapp